Amgen Inc. v. Connecticut Retirement Plans and Trust Funds

Amgen Inc. v. Connecticut Retirement Plans and Trust Funds was a legal case where shareholders accused Amgen, a biotech company, of misleading investors about the seriousness of a safety issue related to its drug. The shareholders argued that Amgen's statements downplayed the risks, potentially affecting stock prices. The case explored whether Amgen's disclosures violated securities laws by being misleading or incomplete. Ultimately, the court examined what information Amgen was required to disclose and whether its communications misled investors, impacting their decision-making and stock value.